A novel protein‐engineered hepatocyte growth factor analog released via a shear‐thinning injectable hydrogel enhances post‐infarction ventricular function
Sign Up to like & getrecommendations! Published in 2017 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.26345
Abstract: In the last decade, numerous growth factors and biomaterials have been explored for the treatment of myocardial infarction (MI). While pre‐clinical studies have demonstrated promising results, clinical trials have been disappointing and inconsistent, likely due… read more here.
Keywords: protein; post infarction; hgfdf; infarction ... See more keywords